Recordati ups guidance on strong growth in specialty, primary care markets

Italian drug maker Recordati hiked its 2023 guidance on Thursday, as it posted first-quarter results showing solid growth for its specialty and primary care segments.... | May 11, 2023

Related Keywords

Milan ,Lombardia ,Italy ,Italian ,Rob Koremans ,Alvise Armellini ,Enrico Sciacovelli , ,Executive Rob Koremans ,Recordati Stock Exchange ,News ,Information ,Press Release ,Drug ,Baker ,Recordati ,Biked ,Its ,023 ,Guidance ,N ,Us ,It ,Osted ,Results ,Showing ,Olid ,Growth ,Or ,Specialty ,End ,Primary ,Are Rec It0003828271 ,